Are you able to elaborate a little on bisantrene "behaved the same way" as gene knockdown?
Does that refer to the shape of the graph of reaction rate (y) to drug concentration (x)? And if so, how does one measure "concentration" of gene knockdown?
Please feel free to respond with just a link or an external reference if that's more convenient than correcting my misconceptions in writing.
Thank you for the ongoing Biotech Investment 101 course. My lecture notes are almost 100 pages now.
Pillar 1 - FTO (new thread), page-434
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.000(0.00%) |
Mkt cap ! $283.7M | |||
| Open | High | Low | Value | Volume |
| $1.70 | $1.70 | $1.66 | $85.03K | 50.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21581 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.70 | 4979 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |